Recombinant Human Serum Albumin/Granulocyte Colony-Stimulating Factor Fusion Protein
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Recombinant Human Serum Albumin/Granulocyte Colony-Stimulating Factor Fusion Protein, covering 2017-07-18 to 2019-09-13. Get the full timeline:
Most recent: Clinical Trial Update: Recombinant Human Serum Albumin/Granulocyte Colony Stimulating Factor Fusion Protein for Breast Cancer Patients [Phase 2]